Library

X
feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Sprague-Dawley-Ratten  (3)
  • Metastatic breast cancer  (2)
  • 1
    Electronic Resource
    Electronic Resource
    On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer (1987)
    Springer
    Journal of molecular medicine 65 (1987), S. 959-966 
    Details
    ISSN: 1432-1440
    Keywords: Metastatic breast cancer ; Hormone monotherapy ; Tamoxifen ; Medroxyprogesterone acetate ; Aminoglutethimide ; Remission rates and duration ; Survival times
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary We analyzed the results of clinical studies on the therapeutic efficacy of hormone monotherapy with tamoxifen, medroxyprogesterone acetate, and aminoglutethimide in metastatic breast cancer, which were published between 1971 and 1986 and involved altogether 7000 patients. The overall response rates in patients treated with these hormonal single agents at various dose levels ranged from 31%–42%. When only estrogen receptor-positive patients were considered, the response rates lay between 41% and 54% in groups which were treated with the antiestrogenic agents tamoxifen or aminoglutethimide. The duration of remission was 12 months for tamoxifen- and aminoglutethimide-treated women, whereas medroxy-progesterone acetate effected remissions lasting from 6–16 months. The overall mean survival from start of therapy in tamoxifen- and aminoglutethimide-treated groups was 20 months, whereas information concerning this therapeutic parameter was available only in a minority of medroxyprogesterone acetate-treated groups. With respect to the response by site of metastatic lesions, all three agents caused a significantly higher degree of remissions in the soft tissue as compared to visceral disease.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/BF01717830
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 2
    Electronic Resource
    Electronic Resource
    Antitumor activity of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (MeCCNU) on yoshida sarcoma ascites cells implanted into the colon wall of rats (1979)
    Springer
    Journal of cancer research and clinical oncology 94 (1979), S. 63-67 
    Details
    ISSN: 1432-1335
    Keywords: Sprague-Dawley-Ratten ; Verimpfen von Yoshida-Sarkom-Zellen ; Colon descendens ; Cyclophosphamid ; BCNU ; Methyl-CCNU ; Sprague-Dawley rats ; Inoculation of Yoshida sarcoma cells ; Descending colon ; Cyclophosphamide ; BCNU ; Methyl-CCNU
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary Three thousand Yoshida sarcoma cells were inoculated into the wall of the descending colon of each of 120 male Sprague-Dawley rats. On day 8 after the tumor implantation, the animals were at random divided into four groups of 30 rats each. The effect of cyclophosphamide (70 mg/kg), BCNU (25 mg/kg), and methyl-CCNU (45 mg/kg) after single i.p. application was investigated. The Yoshida sarcoma transplanted into the colon is sensitive to all three chemotherapeutic drugs. At the doses given cyclophosphamide showed the best results. The two nitrosoureas had a comparable antitumor activity but methyl-CCNU showed a more distinct toxic effect. The introduction of this model for testing new cytostatics in animal experiments is discussed.
    Notes: Zusammenfassung Einhundertzwanzig männlichen Sprague-Dawley-Ratten wurden jeweils 3000 Zellen eines Yoshida-Sarkoms in die Wand des Colon descendens verimpft. Am 8. Tag nach der Tumorimplantation wurden die Tiere randomisiert in vier Versuchsgruppen von jeweils 30 Ratten aufgeteilt. Die Wirkung von Cyclophosphamid (70 mg/kg), BCNU (25 mg/kg) und Methyl-CCNU (45 mg/kg) bei einmaliger i.p. Gabe wurde untersucht. Das ins Colon transplantierte Yoshida-Sarkom ist gegeüber allen drei Chemotherapeutika sensibel. Bei den gewählten Dosierungen zeigte Cyclophosphamide die günstigsten Ergebnisse. Die beiden Nitrosoharnstoffe waren in ihrer Antitumoraktivität vergleichbar, während bei Methyl-CCNU die toxischen Wirkungen sich als ausgeprägter erwiesen. Der Einsatz des Modells im Rahmen der tierexperimentellen Prüfung neuer Cytostatika wird diskutiert.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/BF00405350
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 3
    Electronic Resource
    Electronic Resource
    Experimental investigation on the influence upon chemical carcinogenesis: 4th communication (1979)
    Springer
    Journal of cancer research and clinical oncology 93 (1979), S. 57-66 
    Details
    ISSN: 1432-1335
    Keywords: 1,2-Dimethylhydrazine carcinogenesis ; Colon ; Sprague-Dawley rats ; Different diets ; 1,2-Dimethylhydrazin-Carcinogenese ; Kolon ; Sprague-Dawley-Ratten ; Verschiedene Diäten
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Es wurde in 446 Sprague-Dawley-Ratten untersucht, ob die Carcinogenese von 1,2-Dimethylhydrazin (DMH) (Applikationen von 30 mg/kg Körpergewicht für 7 Monate) durch verschiedene Diäten (vegetarische, fett- und cholesterinreiche sowie kohlehydratreiche) beeinflußt werden kann. Ratten, die mit einer vegetarischen oder einer kohlehydratreichen Diät ernährt wurden, zeigten eine deutlich längere Induktionszeit (mediane Induktionszeit 347 bzw.323 Tage) für maligne Tumoren (Colon, Niere, Leber, Gehörgang) als die Tiere der anderen Testgruppen (mediane Induktionszeit zwischen 250 und 282 Tagen); Tiere, die mit einer kohlehydratreichen Diät ernährt wurden, entwickelten mehr benigne Lebertumoren (86%) als Tiere, die mit einer Standarddiät (19%) oder einer vegetarischen Diät (14%) ernährt wurden. Es ist wahrscheinlich, daß quantitative Unterschiede in der Carcinogenbehandlung für einige der festgestellten Unterschiede verantwortlich sind.
    Notes: Summary In a total of 446 Sprague-Dawley rats it was tested whether colon carcinogenesis induced by 1,2-dimethylhydrazine (DMH) (7-monthly applications of 30 mg/kg bodyweight) can be influenced by different diets (vegetarian, high fat, and high cholesterol and rich in carbohydrates). The rats treated with a vegetarian diet or a diet that was rich in carbohydrates showed apparently longer induction times (median induction time 347 days and 323 days, respectively) of the malignant tumors (colon, kidney, liver, ear duct) than animals of the other test groups (median induction times between 250 and 282 days); animals treated with the diet that was rich in carbohydrates developed more benign liver tumors (86%) than animals treated with a standard (19%) or vegetarian diet (14%). It is emphasized that quantitative differences in carcinogen treatment might be responsible for some of the differences observed.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/BF00451440
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 4
    Electronic Resource
    Electronic Resource
    No relevant influence on overall survival time in patients with metastatic breast cancer undergoing combination chemotherapy (1988)
    Springer
    Journal of cancer research and clinical oncology 114 (1988), S. 183-185 
    Details
    ISSN: 1432-1335
    Keywords: Cytotoxic chemotherapy ; First line ; Second line ; Metastatic breast cancer ; Overall survival
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The results of clinical studies dealing with first and second line chemotherapy of metastatic breast cancer published between 1975 and early 1986 which involved 9350 women were reviewed. Our special aim was to evaluate combination chemotherapy and its influence on overall survival in late stage breast cancer patients. No significant improvement in overall survival times was found in this selected group of patients who were treated with intense palliative chemotherapy.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/BF00417834
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 5
    Electronic Resource
    Electronic Resource
    Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats (1981)
    Springer
    Journal of cancer research and clinical oncology 101 (1981), S. 285-302 
    Details
    ISSN: 1432-1335
    Keywords: Yoshida sarcoma ; Descending colon ; 2-Chloroethyl-nitrosoureas ; Sprague-Dawley rats ; Yoshida-Sarkom ; Colon descendens ; 2-Chlorethyl-nitrosoharnstoffe ; Sprague-Dawley-Ratten
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Die chemotherapeutische Wirkung von 12 neu entwickelten Nitrosoharnstoffen wurde vergleichend an Yoshida-Sarkom-Asziteszellen experimentell untersucht, die in die Wand des Colon descendens von Sprague-Dawley-Ratten implantiert worden waren. Cyclophosphamid sowie die Nitrosoharnstoffe BCNU, MeCCNU und Chlorozotocin dienten als positive Kontrolle. Unter den untersuchten Nitrosoharnstoffen zeigten 1-(2-Hydroxyethyl)-3-(2-chlorethyl)-3-nitrosoharnstoff (Hydroxyethyl-CNU), Chlorozotocin, 1-(2-Chlorethyl)-1-nitroso-3-(4-morpholino)-harnstoff, 1-(2-Chlorethyl)-1-nitroso-3-(1-piperidino)-harnstoff, 4-[1-(2-Chlorethyl)-1-nitroso]-3-[4-(2,6-dimethylmorpholino)]-harnstoff und 1-(2-Chlorethyl)-1-nitroso-3-(3,4-methylendioxybenzyl)-harnstoff die stärkste Aktivität in diesem Tumormodell. Auf Grund der vorliegenden Ergebnisse ist Morpholino-CNU als die erfolgversprechendste Substanz unter den neu synthetisierten BCNU-Analogen anzusehen.
    Notes: Summary The chemotherapeutic activity of 12 newly synthesized nitrosoureas was compared in tests using Yoshida sarcoma ascites cells implanted into the wall of the descending colon in Sprague-Dawley rats. Cyclophosphamide and the nitrosoureas, BCNU, MeCCNU, and chlorozotocin served as positive controls. Among the nitrosoureas tested, 1-(2-hydroxyethyl)-3-(2-chloroethyl)-3-nitrosourea (hydroxyethyl-CNU), chlorozotocin, 1-(2-chloroethyl)-1-nitroso-3-(4-morpholino) urea, 1-(2-chloroethyl)-1-nitroso-3-(1-piperidino) urea, 4-[1-(2-chloroethyl)-1-nitroso]-3-[4-(2,6-dimethylmorpholino)] urea, and 1-(2-chloroethyl)-1-nitroso-3-(3,4-methylenedioxybenzyl) urea were found to be the most active compounds in this tumor model. Based on the present results, morpholino-CNU is considered the most promising compound among these newly synthesized BCNU analogues.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/BF00410114
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...